ArticleAIDS and behavior2009
Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions.
Article in AIDS and behavior, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review.American journal of public health · 2016Pooled it
- Medicare Part D's effect on the under- and overuse of medications: a systematic review.Journal of the American Geriatrics Society · 2011Pooled it
- Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review.Journal of the American Geriatrics Society · 2010Pooled it
- Antiretroviral treatment interruption and resumption within 16 weeks among HIV-positive adults in Jinan, China: a retrospective cohort study.Frontiers in public health · 2023Article
- Impact of Medicare Part D on mental health treatment and outcomes for dual eligible beneficiaries with HIV.AIDS care · 2019Article
- Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.Medical care · 2018Article
- Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.Journal of acquired immune deficiency syndromes (1999) · 2016Article
- Navigating Barriers to Vocational Rehabilitation for HIV-Positive Persons.AIDS and behavior · 2016Article
- The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations.AIDS and behavior · 2015Article
- The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.The Lancet. Infectious diseases · 2014Article
- Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy.AIDS patient care and STDs · 2013Article
- Housing status and the health of people living with HIV/AIDS.Current HIV/AIDS reports · 2012Review
- Assessing barriers to health insurance and threats to equity in comparative perspective: the Health Insurance Access Database.BMC health services research · 2012Article
- Social, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected men.PloS one · 2012Article
- Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting.AIDS patient care and STDs · 2012Article
- Medicare Part D and quality of prescription medication use in older adults.Drugs & aging · 2011Review
- Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Antiretroviral (ARV) treatment interruptions are associated with virologic rebound, drug resistance, and increased morbidity and mortality. The Medicare Part D prescription drug benefit, implemented on January 1st, 2006, increased consumer cost-sharing. Consumer cost-sharing is associated with decreased access to medications and adverse clinical outcomes. We assessed the association of Part D implementation with treatment interruptions by studying 125 HIV-infected homeless and marginally housed individuals with drug coverage receiving ARV therapy. Thirty-five percent of respondents reported Medicare coverage and 11% reported ARV interruptions. The odds of ARV interruptions were six times higher among those with Part D coverage and remained significant after adjustment. The majority of Part D-covered respondents reporting ARV interruptions cited increased cost as their primary barrier. Directed interventions to monitor the long-term effects of increased cost burden on interruptions and clinical outcomes and to reduce cost burden are necessary to avoid preventable increases in morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.